Skip to content
    MPC logo

    MPC

    Beijing, ChinaFounded 2008

    MPC (formerly Matrix Partners China) is a Beijing-based venture capital firm founded in 2008 as the China investment arm of Matrix Partners. It focuses on early-stage and early growth deals in China's new economy, deep technology, industrial digitalization, healthcare, and frontier technology sectors.

    Deal activity decreased year-over-year (1 deal in the last 12 months vs 3 prior). Average disclosed round size is $90.9M (across 77 rounds with reported amounts).

    Find people at MPC on Goldilocks AI

    Portfolio

    75

    Fund Size

    $1.6B

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    David Su

    David Su

    Founding Managing Partner

    David Zhang

    David Zhang

    Founding Partner

    Huadong Wang

    Huadong Wang

    Managing Partner

    Stella Wang

    Stella Wang

    Managing Director

    Zhuang Liu

    Zhuang Liu

    Managing Director

    Harry Man

    Harry Man

    Partner

    Ti Tong

    Ti Tong

    Partner

    Joy Zhou

    Joy Zhou

    Director

    Liu Feng

    Liu Feng

    Director

    Weijia Chen

    Weijia Chen

    Director

    Xiaoxiao Tang

    Xiaoxiao Tang

    Director

    Frankie Li

    Frankie Li

    Vice President

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    108 investments
    CompanyRoundAmountDate
    KKnowin IntelligenceUnknown—Aug 2026
    IInverse MatrixSeed$100MJan 2026
    Meshy logoMeshySeries B$400MJan 2026
    RRonovoSeries D$67MSep 2025
    Ronovo Surgical logoRonovo SurgicalSeries D$67MSep 2025
    WWeimaiSeries D$27.3MJan 2025
    Aureka Biotechnologies logoAureka BiotechnologiesSeries A$100MJan 2025
    D3 Bio logoD3 BioUnknown$62MApr 2024
    Grit Bio logoGrit BioSeries B$60MSep 2023
    NebulaGraph logoNebulaGraphSeries A—Sep 2022
    Ucello Therapeutics logoUcello TherapeuticsSeries A$25MFeb 2022
    Logseq logoLogseqSeed$4.1MJan 2022
    DP Technology logoDP TechnologySeries B$100MJan 2022
    MetaX logoMetaXSeries A$154MAug 2021
    Bota Bio logoBota BioSeries B$100MJul 2021
    Linkedcare logoLinkedcareSeries D$100MJun 2021
    RRgentaSeed—May 2021
    OnQuality logoOnQualitySeries A$20MMar 2021
    Triastek logoTriastekSeries B$100MJan 2021
    ODA Class logoODA ClassSeries B$500KJan 2021
    BBota BiosciencesSeries B$100MJan 2021
    Beisen logoBeisenSeries F$260MJan 2021
    Joes Future Food logoJoes Future FoodPre-Seed—Jan 2021
    Nextdata logoNextdataSeries D$135MJan 2021
    XXgimiUnknown$185MJan 2021
    Page 1 of 5

    Top Co-Investors

    Last updated: 20 October 2026